Overview
Thermo Fisher Scientific Inc., based in the United States, is a global leader in the life sciences industry, renowned for providing analytical instruments, reagents, consumables, and software services. Its key projects often revolve around improving diagnostic technology, increasing laboratory efficiency, and advancing personalized medicine through innovation and acquisition. For instance, the company has made significant strides in the genetic sequencing space and is actively involved in producing high-volume COVID-19 testing solutions. It supports complex biochemical research through its extensive product lines and has established collaborations with research institutions and pharmaceutical companies worldwide to expedite scientific discoveries and enhance therapeutic delivery. Thermo Fisher's strategic expansions enhance its robust global footprint in the scientific community, reinforcing its mission to make the world healthier, cleaner, and safer.
AI+ Ask Fintel’s AI assistant about Thermo Fisher Scientific Inc..
Thinking about good questions…
Basic Stats
The share price of Thermo Fisher Scientific Inc. as of 10 July 2025 is € 373,70 / share. The market cap (or net worth) of Thermo Fisher Scientific Inc. as of 10 July 2025 is € 141.258,60 MM.
The Factor Analysis chart (below right) shows a view of Thermo Fisher Scientific Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 141,258.60 MM |
| EV | |
| Shares Out. | 378.00 MM |
| Earnings Date | |
| EPS (TTM) | 17.23 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-09-15 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | 0.14 |
| Beta | 0.60 |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.07 |
| ROE | 0.14 |
| ROIC | 0.08 |
| CROIC | -0.02 |
| OCROIC | 0.10 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | 93.68 /100 |
| Analyst Sentiment | 68.65 /100 |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 8.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Thermo Fisher Scientific Inc. is € 481,84. The forecasts range from a low of € 390,15 to a high of € 691,32. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Thermo Fisher Scientific Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-07-02 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-06-28 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-04-30 | HSBC | Buy | Buy | Maintains |
| 2024-04-25 | Deutsche Bank | Buy | Buy | Maintains |
| 2024-04-25 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-04-25 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-04-25 | Baird | Outperform | Outperform | Maintains |
| 2024-04-17 | HSBC | Buy | Buy | Maintains |
| 2024-04-10 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-04-04 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-03-18 | Citigroup | Neutral | Reiterate | |
| 2024-02-01 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-02-01 | Raymond James | Outperform | Outperform | Maintains |
| 2024-01-24 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2024-01-08 | Bernstein | Outperform | Market Perform | Downgrade |
| 2023-12-18 | HSBC | Buy | Initiate | |
| 2023-12-14 | Baird | Outperform | Outperform | Maintains |
| 2023-12-13 | Wolfe Research | Outperform | Initiate | |
| 2023-12-11 | Citigroup | Buy | Buy | Maintains |
| 2023-10-26 | Citigroup | Buy | Buy | Maintains |
| 2023-10-26 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-10-26 | Stifel | Buy | Buy | Maintains |
| 2023-10-26 | Raymond James | Outperform | Outperform | Maintains |
| 2023-10-26 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-10-26 | Keybanc | Overweight | Sector Weight | Downgrade |
| 2023-10-24 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-10-18 | Raymond James | Outperform | Outperform | Maintains |
| 2023-10-17 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-10-02 | Citigroup | Buy | Buy | Reiterate |
| 2023-09-28 | Bernstein | Outperform | Initiate | |
| 2023-09-06 | Citigroup | Buy | Buy | Reiterate |
| 2023-07-28 | Wells Fargo | Underweight | Underweight | Maintains |
| 2023-07-28 | Raymond James | Outperform | Outperform | Maintains |
| 2023-07-27 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-07-27 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-07-27 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-07-27 | Baird | Outperform | Outperform | Maintains |
| 2023-07-27 | Barclays | Overweight | Overweight | Maintains |
| 2023-07-13 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2023-05-25 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-05-25 | Keybanc | Overweight | Overweight | Maintains |
| 2023-04-27 | Citigroup | Buy | Maintains | |
| 2023-04-27 | RBC Capital | Outperform | Maintains | |
| 2023-04-27 | Morgan Stanley | Overweight | Maintains | |
| 2023-04-27 | TD Cowen | Outperform | Maintains | |
| 2023-04-27 | Baird | Outperform | Maintains | |
| 2023-04-27 | Barclays | Overweight | Maintains | |
| 2023-04-04 | Evercore ISI Group | Outperform | Maintains | |
| 2023-04-04 | Barclays | Overweight | Maintains | |
| 2023-02-02 | Cowen & Co. | Outperform | Maintains | |
| 2023-02-02 | Barclays | Overweight | Maintains | |
| 2023-02-02 | Morgan Stanley | Overweight | Maintains | |
| 2023-02-02 | Citigroup | Buy | Maintains | |
| 2023-02-02 | SVB Leerink | Outperform | Maintains | |
| 2023-01-24 | Barclays | Overweight | Maintains | |
| 2023-01-06 | SVB Leerink | Outperform | Maintains | |
| 2023-01-03 | Wells Fargo | Underweight | Maintains | |
| 2022-12-14 | Deutsche Bank | Buy | Initiate | |
| 2022-12-07 | RBC Capital | Outperform | Initiate | |
| 2022-11-29 | Barclays | Overweight | Maintains | |
| 2022-11-01 | Baird | Outperform | Maintains | |
| 2022-10-27 | Citigroup | Buy | Maintains | |
| 2022-10-27 | Morgan Stanley | Overweight | Maintains | |
| 2022-10-27 | Barclays | Overweight | Maintains | |
| 2022-10-27 | SVB Leerink | Outperform | Maintains | |
| 2022-09-12 | Barclays | Overweight | Maintains | |
| 2022-08-25 | Credit Suisse | Neutral | Initiate | |
| 2022-08-01 | Barclays | Overweight | Maintains | |
| 2022-07-29 | Morgan Stanley | Overweight | Maintains | |
| 2022-07-29 | SVB Leerink | Outperform | Maintains | |
| 2022-07-13 | Barclays | Overweight | Maintains | |
| 2022-04-29 | Morgan Stanley | Overweight | Maintains | |
| 2022-04-25 | Wells Fargo | Equal-Weight | Underweight | Downgrade |
| 2022-02-03 | Wells Fargo | Equal-Weight | Maintains | |
| 2021-12-14 | Wells Fargo | Equal-Weight | Maintains | |
| 2021-10-28 | Citigroup | Buy | Maintains | |
| 2021-10-28 | SVB Leerink | Outperform | Maintains | |
| 2021-10-20 | Citigroup | Neutral | Buy | Upgrade |
| 2021-09-23 | Cowen & Co. | Outperform | Maintains | |
| 2021-09-22 | BTIG | Buy | Maintains | |
| 2021-09-20 | Keybanc | Overweight | Maintains | |
| 2021-08-04 | Argus Research | Buy | Maintains | |
| 2021-07-16 | Benchmark | Buy | Initiate | |
| 2021-07-12 | Keybanc | Overweight | Maintains | |
| 2021-06-23 | Baird | Outperform | Maintains | |
| 2021-06-15 | Goldman Sachs | Buy | Maintains | |
| 2021-04-16 | Evercore ISI Group | Outperform | Maintains | |
| 2021-03-29 | UBS | Buy | Maintains | |
| 2021-03-18 | KeyBanc | Sector Weight | Overweight | Upgrade |
| 2021-03-03 | Barclays | Overweight | Initiate | |
| 2021-02-03 | BTIG | Buy | Maintains | |
| 2021-02-02 | Stifel | Buy | Maintains | |
| 2021-02-02 | Cowen & Co. | Outperform | Maintains | |
| 2021-02-02 | UBS | Buy | Maintains | |
| 2021-02-02 | Citigroup | Buy | Maintains | |
| 2021-02-02 | Morgan Stanley | Overweight | Maintains | |
| 2021-02-02 | SVB Leerink | Outperform | Maintains | |
| 2021-01-12 | Credit Suisse | Outperform | Maintains | |
| 2021-01-08 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2020-12-16 | Citigroup | Buy | Neutral | Downgrade |
| 2020-12-02 | Credit Suisse | Neutral | Maintains | |
| 2020-11-10 | KeyBanc | Sector Weight | Initiate | |
| 2020-10-22 | Credit Suisse | Neutral | Maintains | |
| 2020-10-22 | Morgan Stanley | Overweight | Maintains | |
| 2020-10-22 | SVB Leerink | Outperform | Maintains | |
| 2020-09-30 | Atlantic Equities | Overweight | Initiate | |
| 2020-09-17 | Needham | Buy | Maintains | |
| 2020-09-14 | Morgan Stanley | Overweight | Initiate | |
| 2020-09-11 | Credit Suisse | Neutral | Maintains | |
| 2020-09-11 | B of A Securities | Buy | Maintains | |
| 2020-09-11 | SVB Leerink | Outperform | Maintains | |
| 2020-08-21 | Credit Suisse | Neutral | Maintains | |
| 2020-08-20 | JP Morgan | Overweight | Reiterate | |
| 2020-07-23 | SVB Leerink | Outperform | Maintains | |
| 2020-07-23 | Needham | Buy | Maintains | |
| 2020-07-15 | Cleveland Research | Neutral | Buy | Upgrade |
| 2020-07-07 | Needham | Buy | Maintains | |
| 2020-04-23 | Citigroup | Buy | Maintains | |
| 2020-04-23 | Needham | Buy | Maintains | |
| 2020-04-21 | Wells Fargo | Equal-Weight | Maintains | |
| 2020-04-02 | Stifel | Buy | Maintains | |
| 2020-03-30 | Wells Fargo | Equal-Weight | Maintains | |
| 2020-03-20 | Citigroup | Buy | Maintains | |
| 2020-03-04 | Baird | Outperform | Maintains | |
| 2020-01-31 | Baird | Outperform | Maintains | |
| 2020-01-31 | Citigroup | Buy | Maintains | |
| 2020-01-31 | BTIG | Buy | Maintains | |
| 2020-01-31 | Wells Fargo | Equal-Weight | Maintains | |
| 2020-01-22 | Credit Suisse | Neutral | Initiate | |
| 2020-01-08 | Wells Fargo | Equal-Weight | Initiate | |
| 2020-01-07 | Citigroup | Buy | Initiate | |
| 2019-11-15 | Stifel Nicolaus | Buy | Initiate | |
| 2019-10-24 | Baird | Outperform | Maintains | |
| 2019-07-25 | Needham | Buy | Maintains | |
| 2019-07-16 | Needham | Strong Buy | Buy | Downgrade |
| 2019-05-23 | UBS | Buy | Maintains | |
| 2019-05-01 | Argus Research | Buy | Buy | Maintains |
| 2019-03-26 | Baird | Outperform | Outperform | Maintains |
| 2019-03-22 | Deutsche Bank | Buy | Buy | Maintains |
| 2019-03-18 | Barclays | Overweight | Overweight | Maintains |
| 2019-01-03 | Barclays | Overweight | Overweight | Maintains |
| 2019-01-03 | Needham | Strong Buy | Initiate | |
| 2018-10-25 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-10-25 | Baird | Outperform | Outperform | Maintains |
| 2018-10-18 | Cleveland Research | Buy | Neutral | Downgrade |
| 2018-10-10 | Citigroup | Buy | Buy | Maintains |
| 2018-10-10 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-09-24 | Barclays | Overweight | Overweight | Maintains |
| 2018-09-17 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2018-07-26 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-07-13 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-04-26 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-04-11 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-02-01 | Bank of America | Buy | Buy | Maintains |
| 2018-02-01 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-02-01 | Barclays | Overweight | Overweight | Maintains |
| 2018-01-05 | BTIG Research | Buy | Initiate | |
| 2018-01-04 | Evercore ISI Group | Outperform | Initiate | |
| 2017-10-26 | Deutsche Bank | Buy | Maintains | |
| 2017-10-09 | Leerink Swann | Outperform | Maintains | |
| 2017-09-25 | Barclays | Overweight | Maintains | |
| 2017-05-19 | Cantor Fitzgerald | Overweight | Initiate | |
| 2017-01-18 | Deutsche Bank | Buy | Initiate | |
| 2017-01-17 | Deutsche Bank | Buy | Initiate | |
| 2016-09-21 | UBS | Buy | Maintains | |
| 2016-09-09 | Cleveland Research | Buy | Neutral | Downgrade |
| 2016-07-29 | Citigroup | Buy | Maintains | |
| 2016-07-19 | Barclays | Overweight | Maintains | |
| 2016-04-29 | Jefferies | Buy | Hold | Downgrade |
| 2016-01-06 | Avondale Partners | Market Outperform | Initiate | |
| 2016-01-06 | Deutsche Bank | Buy | Initiate | |
| 2015-07-23 | Leerink Swann | Outperform | Maintains | |
| 2015-07-23 | Baird | Outperform | Maintains | |
| 2015-05-21 | JP Morgan | Overweight | Maintains | |
| 2015-05-21 | Jefferies | Buy | Maintains | |
| 2015-05-21 | Barclays | Overweight | Maintains | |
| 2015-03-10 | UBS | Buy | Initiate | |
| 2014-10-23 | Stifel Nicolaus | Buy | Maintains | |
| 2014-10-03 | BTIG Research | Neutral | Initiate | |
| 2014-09-08 | Morgan Stanley | Overweight | Initiate | |
| 2014-08-12 | Stifel Nicolaus | Buy | Initiate | |
| 2014-07-24 | Macquarie | Outperform | Maintains | |
| 2014-03-21 | Bank of America | Buy | Maintains | |
| 2014-02-20 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2014-01-31 | Morgan Stanley | Overweight | Maintains | |
| 2014-01-06 | Morgan Stanley | Overweight | Maintains | |
| 2013-12-12 | Bank of America | Buy | Maintains | |
| 2013-10-24 | Jefferies | Buy | Maintains | |
| 2013-08-15 | Janney Capital | Buy | Initiate | |
| 2013-04-17 | Jefferies | Buy | Maintains | |
| 2013-04-16 | Credit Suisse | Outperform | Maintains | |
| 2013-04-04 | UBS | Buy | Maintains | |
| 2013-02-14 | Citigroup | Buy | Maintains | |
| 2013-02-01 | Jefferies | Buy | Maintains | |
| 2013-02-01 | Credit Suisse | Outperform | Maintains | |
| 2013-02-01 | JP Morgan | Neutral | Overweight | Upgrade |
| 2013-02-01 | UBS | Buy | Maintains | |
| 2013-01-31 | ISI Group | Buy | Maintains | |
| 2013-01-31 | Bank of America | Buy | Maintains | |
| 2013-01-31 | Jefferies | Buy | Maintains | |
| 2012-10-25 | UBS | Buy | Maintains | |
| 2012-10-25 | Credit Suisse | Outperform | Maintains | |
| 2012-10-25 | Jefferies | Buy | Maintains | |
| 2012-10-24 | JP Morgan | Neutral | Maintains | |
| 2012-10-24 | Jefferies | Buy | Maintains | |
| 2012-10-24 | ISI Group | Overweight | Maintains | |
| 2012-10-24 | Cantor Fitzgerald | Buy | Maintains | |
| 2012-10-24 | Goldman Sachs | Neutral | Maintains | |
| 2012-08-09 | Wallachbeth | Buy | Initiate | |
| 2012-07-26 | Jefferies | Buy | Maintains | |
| 2012-07-25 | ISI Group | Overweight | Maintains | |
| 2012-07-23 | Barclays | Overweight | Maintains | |
| 2012-07-10 | ISI Group | Overweight | Initiate | |
| 2012-04-26 | UBS | Buy | Maintains | |
| 2012-04-25 | JP Morgan | Neutral | Maintains | |
| 2012-03-06 | Morgan Stanley | Overweight | Initiate | |
| 2024-08-27 | Wells Fargo | Overweight | Initiate | |
| 2025-04-29 | Argus Research | Buy | Buy | Maintains |
| 2025-04-17 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-10-01 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-09-16 | B of A Securities | Buy | Buy | Maintains |
| 2024-12-13 | B of A Securities | Buy | Buy | Maintains |
| 2025-02-03 | Scotiabank | Sector Perform | Sector Perform | Maintains |
| 2025-02-03 | Raymond James | Outperform | Outperform | Reiterate |
| 2024-07-25 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-07-25 | Raymond James | Outperform | Outperform | Maintains |
| 2024-07-25 | TD Cowen | Buy | Buy | Maintains |
| 2024-07-25 | Stifel | Buy | Buy | Maintains |
| 2024-07-25 | Baird | Outperform | Outperform | Maintains |
| 2024-09-20 | Stifel | Buy | Buy | Maintains |
| 2024-09-20 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-09-20 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-09-20 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-04-25 | Scotiabank | Sector Perform | Sector Perform | Maintains |
| 2025-04-24 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-04-24 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2025-04-24 | Baird | Outperform | Outperform | Maintains |
| 2024-10-24 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-10-24 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-10-24 | Stifel | Buy | Buy | Maintains |
| 2024-10-24 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-10-24 | Bernstein | Market Perform | Market Perform | Maintains |
| 2024-10-24 | Baird | Outperform | Outperform | Maintains |
| 2024-10-23 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-14 | Redburn Atlantic | Buy | Initiate | |
| 2024-12-23 | Scotiabank | Sector Perform | Initiate | |
| 2025-01-31 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-01-31 | UBS | Buy | Buy | Maintains |
| 2025-01-31 | Citigroup | Neutral | Neutral | Maintains |
| 2025-01-31 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2024-10-01 | Stephens & Co. | Overweight | Initiate | |
| 2025-04-10 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-15 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-03-04 | Citigroup | Neutral | Neutral | Maintains |
| 2025-01-13 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-04-24 | Stifel | Buy | Buy | Maintains |
| 2025-04-24 | UBS | Buy | Buy | Maintains |
| 2025-04-24 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-06-24 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-07-11 | Scotiabank | Sector Perform | Sector Outperform | Upgrade |
| 2025-07-18 | Baird | Outperform | Outperform | Maintains |
| 2025-07-24 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-07-24 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-07-24 | Baird | Outperform | Outperform | Maintains |
| 2025-08-19 | William Blair | Outperform | Initiate | |
| 2025-07-09 | UBS | Buy | Neutral | Downgrade |
| 2025-07-24 | Raymond James | Outperform | Outperform | Reiterate |
| 2025-07-24 | UBS | Neutral | Neutral | Maintains |
| 2025-07-08 | Evercore ISI Group | Outperform | Outperform | Maintains |
